← Back to headlines
Insilico Medicine, SK Biopharmaceuticals strike $2.5B AI drug discovery deal
Insilico Medicine and SK Biopharmaceuticals have announced a $2.5 billion deal focused on AI drug discovery, specifically targeting neuroimmune therapies.
22 Jun, 21:00 — 22 Jun, 21:00
Sources
Showing 1 of 1 sources
Related Stories
Apple Unveils Foldable iPhone Duo and Next-Generation Device Lineup
31m ago
Google Commits $15 Billion to AI Infrastructure and Nuclear Power in Finland
1h ago
White House Removes 'Build the Wall' Game After Tetris Copyright Complaint
3h ago
Meta Stock Rallies on Muse AI Rollout Amid Separate Terror Charges
3h ago